Study Evaluating the Efficacy of a Double Immunotherapy Combined With Olaparib in Patients With Solid Cancers and Carriers of Homologous Recombination Repair Genes After Olaparib Treatment

NCT04169841 · clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
270
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Centre Georges Francois Leclerc

Collaborators